Altimmune (ALT) Payables (2010 - 2026)
Altimmune (ALT) reported Payables of $1.27 million for Q2 2026, up 49.5% from $851,000 a year earlier but down 16.9% from the prior quarter.
Analysis
Altimmune (ALT) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Altimmune posted Payables of $2.72 million.
- Payables has a five-year compound annual growth rate of 34.7% (FY2020 to FY2025).
- By year, Payables came in at $211,000 in FY2024 (-89.8%), $2.07 million in FY2023 (-56.9%), $4.8 million in FY2022 (+136.2%) and $2.03 million in FY2021 (+232.2%).
- Five-year quarterly Payables spans a low of $6,083 in Q3 2021 and a high of $5.24 million in Q1 2023.
- Year over year, Payables gained in three of the last seven quarters, with growth averaging 17.6%.
- The high point for year-over-year Payables in five years was Q1 2022 (growth of 427.2%); the low point was Q3 2021 (a decline of 99.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.53 million (Q1 2026), $2.72 million (Q4 2025) and $4.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Altimmune | 575.64 Mn | 575.64 Mn | - | 1.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 851,000.00 |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 211,000.00 |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 2.69 Mn |
| Mar 31, 2024 | 3.76 Mn |
| Dec 31, 2023 | 2.07 Mn |
| Sep 30, 2023 | 3.05 Mn |
| Jun 30, 2023 | 4.04 Mn |
| Mar 31, 2023 | 5.24 Mn |
| Dec 31, 2022 | 4.80 Mn |
| Sep 30, 2022 | 1.42 Mn |
| Jun 30, 2022 | 2.87 Mn |
| Mar 31, 2022 | 2.21 Mn |
| Dec 31, 2021 | 2.03 Mn |
| Sep 30, 2021 | 6,083.00 |
API Access
Altimmune Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ALT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();